Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Eden Research ( (GB:EDEN) ) is now available.
Eden Research has secured approximately £3.1 million through a firm placing and subscription of new shares and has conditionally raised a further £7.6 million via a placing, both at 4.0 pence per share, alongside plans for a retail offer of up to £0.5 million to existing shareholders. The proceeds will be used to accelerate registration and commercialisation of a new insecticide and a Late Blight fungicide, develop a broad-acre fungicide for Septoria in wheat, and scale commercial and operational activities, which the company expects will bring key products to market 2–3 years earlier than funding via internal cash flow, strengthening its growth prospects and position in the sustainable crop protection market.
The most recent analyst rating on (GB:EDEN) stock is a Hold with a £4.00 price target. To see the full list of analyst forecasts on Eden Research stock, see the GB:EDEN Stock Forecast page.
Spark’s Take on GB:EDEN Stock
According to Spark, TipRanks’ AI Analyst, GB:EDEN is a Neutral.
The score is held back primarily by weak financial performance—ongoing losses and persistently negative operating/free cash flow—despite revenue growth and a relatively stable balance sheet. Technicals are supportive due to strong price momentum above key moving averages, but extremely overbought readings raise pullback risk. Valuation is neutral-to-cautious because the negative P/E reflects lack of profitability and there is no dividend yield data.
To see Spark’s full report on GB:EDEN stock, click here.
More about Eden Research
Eden Research plc, listed on AIM, is a UK-based leader in sustainable biopesticide and biocontrol technologies focused on environmentally friendly crop protection. The company develops bioactive products including the biofungicide Mevalone, the bionematicide Cedroz, and the bird-repellent seed treatment Ecovelex, and positions itself as the only UK-quoted company dedicated to biopesticides for sustainable agriculture, targeting growing global demand for alternatives to conventional agrochemicals.
Average Trading Volume: 553,155
Technical Sentiment Signal: Buy
Current Market Cap: £20.8M
For detailed information about EDEN stock, go to TipRanks’ Stock Analysis page.